7-1-2021: In a 407-patient clinical trial just released today from Rome, Italy, remdesivir had zero efficacy against COVID-19 in humans https://t.co/CJbookg0eR https://t.co/IUyTSfhF2o https://t.co/fmoCGINNPG https://t.co/3BkvmkRbbF https://t.co/9HLa7F35HN
@ydeigin Remdesivir Removed from who protocol. https://t.co/U2qRpKEKN8
RT @zbiotech: $GILD remdesivir impact on viral load, lancet pub 'Viral load decreased over time similarly in both groups. No differences…
Remdes has always been useless, but immediately applauded by Fauci. Other effective options repeatedly ignored. Disgraceful
RT @zbiotech: $GILD remdesivir impact on viral load, lancet pub 'Viral load decreased over time similarly in both groups. No differences…
RT @zbiotech: $GILD remdesivir impact on viral load, lancet pub 'Viral load decreased over time similarly in both groups. No differences…
RT @zbiotech: $GILD remdesivir impact on viral load, lancet pub 'Viral load decreased over time similarly in both groups. No differences…
$GILD remdesivir impact on viral load, lancet pub 'Viral load decreased over time similarly in both groups. No differences in viral load were observed when stratified by interval from symptom onset to start of study treatment' $AVIR https://t.co/fJZNZP
''In summary,we found that this dose regimen of intravenous remdesivir was adequately tolerated but did not provide significant clinical or antiviral effects in seriously ill patients with COVID-19.'' https://t.co/x3VC7MrtQL https://t.co/FLfeIF5vod https:
@JulbertIsBack @fmbreon @Citoyen52037193 @Citizen4Sci @afis_science Si, il avait des données sur le Remdesivir dès fin avril. Le bras de Discovery a été arrêté seulement 9 mois après... https://t.co/lKpMwSaoN0
@Serres32742451 @LE_GENERAL_OFF @BarneriasPierre Primo on parle de vaccin et vous parlez de Remdesivir. Secundo Avant de dire quelque chose vérifiez le : https://t.co/gfLCBGATxl Personne ne prescrit de Remdesivir depuis plus d'un an.
RT @Nat_anest: Первые два исследования по Ремдесивиру https://t.co/qKzHyeUnpr
RT @my69z: "Dr. Frederick Hayden is a non compensated consultant to Gilead Sciences" Also listed on an early China Remdesivir study https:/…
"Dr. Frederick Hayden is a non compensated consultant to Gilead Sciences" Also listed on an early China Remdesivir study https://t.co/kXpTiFPoHt Would like to know what justified going to 42 days, when we did not have many deaths outside of Day 28
@Lakshmoji @tejas_vb @drvaishali_ @Neurophysik I know it wouldn't matter for most people following this govt don't like to read, least of all science - but still....(just one of multiple reports) - hope you know how to use Google.. if not- try "Remdesivir,
Hocam siz "klorikin işe yaramıyor" dediğiniz dönemde Remdesivir övüyordunuz. Sonra tedavide etkisiz olduğu ispatlandı ama "hata ettim" dediğinizi göremedik: https://t.co/z4BURzHWjD
@MartineWonner @EmmanuelMacron @olivierveran @Conseil_Etat @Laissonslespre1 Par ailleurs, le Remdesivir ça ne fonctionne pas ! https://t.co/aaKfC6djJ9 https://t.co/B5Yt5fWMxH
@Arshiethromycin basa basa about favorite drug of choice sa hospital "Remdesivir use was not associated with a difference in time to clinical improvement" at "Remdesivir was stopped early because of adverse events" https://t.co/jcHQWdnkOm
RT @picphysicians: Did you know Remdesivir was not associated with clinical benefits that were statistically significant? https://t.co/qnBc…
RT @picphysicians: Did you know Remdesivir was not associated with clinical benefits that were statistically significant? https://t.co/qnBc…
RT @picphysicians: Did you know Remdesivir was not associated with clinical benefits that were statistically significant? https://t.co/qnBc…
RT @picphysicians: Did you know Remdesivir was not associated with clinical benefits that were statistically significant? https://t.co/qnBc…
RT @picphysicians: Did you know Remdesivir was not associated with clinical benefits that were statistically significant? https://t.co/qnBc…
Did you know Remdesivir was not associated with clinical benefits that were statistically significant? https://t.co/qnBc9UjIZQ Want to stay informed? https://t.co/tieJwPrrmZ #coronavirus #COVID19 #COVID_19 #PublicHealth #1stDoNoHarm #InformedConsent #Sc
5-1-2021: "My father came home from work and can't breathe" https://t.co/kqU58ClGoC https://t.co/fmoCGINNPG https://t.co/IUyTSfhF2o https://t.co/CJbookg0eR https://t.co/YtrFRh2FbH https://t.co/3BkvmkRbbF https://t.co/DAQHZoyDsD https://t.co/G7ieZgGt21 htt
RT @Arshiethromycin: SOURCES: 1.[THE LANCET]Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, mult…
RT @Arshiethromycin: SOURCES: 1.[THE LANCET]Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, mult…
SOURCES: 1.[THE LANCET]Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial https://t.co/bHUucy1Shb 2.[NIH] Final report confirms remdesivir benefits for COVID-19 https://t.co/HTiENceJUr
RT @aragon_jb: @olivierveran @TheLancet @hcsp_fr Pas de lumières de #Discovery ? Donc du Lancet ? Bah alors faites plancher plutôt le HCSP…
@alezan85 @f_philippot 1-Biensur que le mode de transmission passe par les gouttelettes ⤵️ https://t.co/N8EtliprMq 2-Citer The Lancet quand il dit que le Remdesivir ne marche pas, ça ne vous pose pas de problème, mais quand il s’agit des masque, alerte, v
RT @coffeestains11: @ikaveri Even worse is the fact that this known for ONE YEAR. ICMR after conducting its own trials, declared in May 202…
@ikaveri Even worse is the fact that this known for ONE YEAR. ICMR after conducting its own trials, declared in May 2020 that it does not work (along with Fabiflu, Hydro...) is still allowing this to happen... making patient families go through hell. http
RT @sajanpv: #REMDESIVIR being used for #COVID19 doesn't offer any statistically significant relief. Many other expensive drugs are being…
#REMDESIVIR being used for #COVID19 doesn't offer any statistically significant relief. Many other expensive drugs are being indiscriminately used in the treatment, leading to the shortage, black-marketing of these drugs crucial for other ailments. https
https://t.co/tEa2qs5Enj #remdesivir conflicting evidence
@dw_brasil 3 - Em tempo: https://t.co/4ztIG5cUnX
@maine_kaha @smileandshine20 @indiacares_2020 @ipskabra @arunbothra @itsmesabita @mojilo_manas @_pulkitg @bir_sahi @sah_anuradha @dipika_bajpai @US_FDA Kindly read this from Lancet- Although not statistically significant, patients receiving remdesivir had
adult patients admitted to hospital for severe COVID-19, remdesivir was not asso with statistically significant clinical benefits.However,numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.
@rrr77S01902885 @deepaksingh021 @Kumkum26 Just go through this https://t.co/NO3DIjhAAr A medical journal
RT @ompsychiatrist: Although not statistically significant, patients receiving remdesivir had a numerically faster time to clinical improve…
Although not statistically significant, patients receiving remdesivir had a numerically faster time to clinical improvement than those receiving placebo among patients with symptom duration of 10 days or less https://t.co/48ZMbzeWXL
RT @adhicutting: The published paper's here: https://t.co/wK5gy0nd0r
The published paper's here: https://t.co/wK5gy0nd0r
RT @josh_danac: They subtly try to discredit remdesivir by pointing at ONE study (https://t.co/Bpp4ktaBom) but they don’t seem qualified to…
RT @josh_danac: They subtly try to discredit remdesivir by pointing at ONE study (https://t.co/Bpp4ktaBom) but they don’t seem qualified to…
RT @josh_danac: They subtly try to discredit remdesivir by pointing at ONE study (https://t.co/Bpp4ktaBom) but they don’t seem qualified to…
RT @josh_danac: They subtly try to discredit remdesivir by pointing at ONE study (https://t.co/Bpp4ktaBom) but they don’t seem qualified to…
They subtly try to discredit remdesivir by pointing at ONE study (https://t.co/Bpp4ktaBom) but they don’t seem qualified to interpret this bc (1) even this one shows reduced time to recovery (main benefit for remdesivir) (2) remdesivir has been shown for e
@FasoliGabriela @juanmanuelxico @Pajaropolitico @COFEPRIS Para que una investigación tenga validez, debe llevar sus fases de realización(son meses), este estudio fue publicado en The Lancet y para ser publicado tiene que llevar estás fases, de forma resumi
@boticariors @CMIJournal @MariadelMarTom @pacificjulio @Virusemergentes @quequesierra @MartinQuirosMD @japineda_ @nicomerchante @ligero999 @carol_perelman El primer ensayo clínico chino de remdesivir tampocó vio diferencias en carga viral https://t.co/LVX
RT @revoltes: @Covid19Crusher @JeanYvesCAPO Remdesivir was proved to be both inefficient and toxical, particularly for kidneys. Since nearl…
RT @revoltes: @Covid19Crusher @JeanYvesCAPO Remdesivir was proved to be both inefficient and toxical, particularly for kidneys. Since nearl…
RT @revoltes: @Covid19Crusher @JeanYvesCAPO Remdesivir was proved to be both inefficient and toxical, particularly for kidneys. Since nearl…
RT @revoltes: @Covid19Crusher @JeanYvesCAPO Remdesivir was proved to be both inefficient and toxical, particularly for kidneys. Since nearl…
Le remdesivir s'est avéré à la fois inefficace et toxique, en particulier pour les reins. Depuis près de 6 mois. https://t.co/0fZt9wX8fZ
RT @revoltes: @Covid19Crusher @JeanYvesCAPO Remdesivir was proved to be both inefficient and toxical, particularly for kidneys. Since nearl…
@Covid19Crusher @JeanYvesCAPO Remdesivir was proved to be both inefficient and toxical, particularly for kidneys. Since nearly 6 months. https://t.co/hMrCnnl402 https://t.co/pl6kBBcOiZ
@BLOGDOMENON @MiguelNicolelis @zehdeabreu Em outubro de 2020 Remdesivir foi aprovado na FDA com ensaios relativamente pequenos (cerca de 1.000 participantes) Porém em vários estudos não afetou significativamente tempo de recuperação + mortalidade+ tempo
Já faz quase um ano que foi publicado um estudo mostrando que não é eficaz... https://t.co/crYD5EDi59
3-10-2021: REMDACTA fails to show any benefit of adding Actemra to remdesivir, indicating a bad drug interaction https://t.co/9HLa7F35HN https://t.co/YtrFRh2FbH https://t.co/3BkvmkRbbF https://t.co/fmoCGINNPG https://t.co/IUyTSfhF2o https://t.co/CJbookg0eR
RT @7thclouds: @19840615Ch @knkn3 英米いずれでも #レムデシベル の副作用に肺機能障害等深刻な副作用の報告はないが英国ランチェットは「#新型コロナウイルス への効果の有意性疑問 https://t.co/snJXIXA83p」「米国FDAはレム…
RT @raoult_didier: Deux études sur le remdesivir ont apporté leurs résultats : une publiée dans le Lancet, qui conclut à la non-efficacité…
RT @norabar: El estudio de @TheLancet que no muestra beneficios significativos del remdesivir en pacientes graves con Covid-19 https://t.co…
RT @norabar: El estudio de @TheLancet que no muestra beneficios significativos del remdesivir en pacientes graves con Covid-19 https://t.co…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @Excalibrute: Prochain ministère pour veran 😈 https://t.co/T1HdYonuUN https://t.co/0aRtAz5Qk6
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…
RT @medicalfollower: A quand l’enquête? ➡️ Avril 2020 Le Lancet publie un RCT en double aveugle sur l'inefficacité du #Remdesivir. La 🇫🇷 a…